Department of Neurosurgery, XinHua Hospital, Shanghai JiaoTong University School of Medicine, Yangpu District, China.
Acta Neurochir (Wien). 2010 Dec;152(12):2113-8. doi: 10.1007/s00701-010-0837-9. Epub 2010 Oct 10.
Microvascular decompression (MVD) is the only solution that can effectively control hemifacial spasm (HFS). Regarding treatment of the patients who failed the first operation, it is still controversial. We tried to evaluate the safety and efficiency of the early re-exploration for such kinds of patients.
Thirteen patients failed the first MVD and received a second MVD procedure. The spasm was not resolved at all or became even more severe after the first MVD. Abnormal muscle response (AMR) persisted during the first MVD operation or disappeared once but emerged again. The patient had a strong will to do the re-operation and was aware of the high risks of operative complications.
All the 13 patients got good or excellent spasm resolution immediately after the re-operation, which involved whole-range exploration and intraoperative AMR monitoring; however, there were two cases (15.4%) of permanent facial weakness and three cases (23.0%) of transient facial weakness.
Our experience on early repeat MVD is whole-range exploration and intraoperative AMR monitoring; in other words, re-operation cannot rely too much on experience.
微血管减压术(MVD)是唯一能有效控制面肌痉挛(HFS)的方法。对于第一次手术失败的患者,治疗方法仍存在争议。我们试图评估对这类患者进行早期再次探查的安全性和有效性。
13 例患者首次 MVD 治疗失败后接受了第二次 MVD 手术。第一次 MVD 后,痉挛完全未缓解或加重。第一次 MVD 手术过程中持续存在异常肌反应(AMR)或消失后再次出现。患者强烈希望再次手术,且了解手术并发症的高风险。
所有 13 例患者在再次手术后即刻获得良好或极佳的痉挛缓解效果,手术范围为全范围探查,并进行术中 AMR 监测;然而,有 2 例(15.4%)患者出现永久性面瘫,3 例(23.0%)患者出现暂时性面瘫。
我们在早期重复 MVD 方面的经验是全范围探查和术中 AMR 监测;换句话说,再次手术不能过于依赖经验。